| Application no. and date | 02753549.1 (espacenet) (Federated) (European Patent Register), 20020827 | | Patent/reg. no. and date | DK/EP 1420759, 20090506 | | Publication date | 20040526 | | Priority no. and date | US 315386 P, 20010828 | | EP pub. no. and date |
EP 1420759 20040526 | | Effective date | | | Applicant/owner | Merck Sharp & Dohme LLC, 126 East Lincoln Avenue
Rayway, New Jersey 07065, US | | Applicant ref. no. | 152936 | | Inventor | SEQUEIRA, Joel, A., 6 Mary Ellen Drive
Edison, NJ 08820, US,
SHARPE, Stefan, A., 270 5th Street
Jersey City, NJ 07302, US,
HART, John, L., 12 Cobble Lane
Bedminster, NJ 07921, US | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 9/12 (2006.01) | | Title | Farmaceutiske sammensætninger til behandling af astma | | Int. application no. | US2002027336 | | Int. publication no. | WO2003020253 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
